Skip to content

ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes

ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07460583
Enrollment
100
Registered
2026-03-10
Start date
2026-04-28
Completion date
2026-12-31
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Atherosclerosis Due to Calcified Coronary Lesion

Brief summary

AI-Guided Coronary CT Angiography Screening in Former High-Intensity Athletes

Detailed description

A prospective, interventional, single-center study to determine the prevalence and characteristics (burden, composition, risk features) of coronary atherosclerosis in former high-intensity athletes using AI-guided software to analyze a CCTA.

Interventions

The Coronary CTA will be performed for each participant. These images will be analyzed using AI-software to assess plaque quantification and an ischemia analysis, if necessary.

Sponsors

Baylor Research Institute
Lead SponsorOTHER
Cleerly, Inc.
CollaboratorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Former professional or collegiate high-intensity athletes (e.g., NFL alumni, Division I athletes, or equivalent competitive-level participants). * Age ≥30 years

Exclusion criteria

* eGFR \<40 mL/min/1.73 m² * Known iodinated contrast allergy * Weight \>450 lbs. (scanner table limit) * Inability to hold breath \>10 seconds * Uncontrolled arrhythmia * Contraindication to beta-blocker, Calcium Channel Blockers and nitroglycerin * Taking part in another research study that has not given their permission to participate in this one * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of Coronary AtherosclerosisAt CCTA assessmentThe primary outcome is to determine the prevalence of coronary atherosclerosis in former high-intensity athletes using AI-guided software to analyze a CCTA.
Coronary Atherosclerosis CharacteristicsAt CCTA AssessmentDetermine the characteristics (burden, composition, risk features) of coronary atherosclerosis in former high-intensity athletes using AI-guided software to analyze a CCTA.

Secondary

MeasureTime frameDescription
Plaque BurdenDay of CCTA and biomarker collectionThe secondary outcome is to correlate plaque burden with biomarkers (Lipid panel, HbA1c).

Countries

United States

Contacts

CONTACTBonnie Ostergren
bonnie.ostergren@bswhealth.org469-814-4181

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026